Table 2.
Antiviral Drugs | Mechanisms/Targets | Virus | IC50/EC50 Value | Reference |
---|---|---|---|---|
Paxlovid | 3CLpro and CYP3A4 | SARS-CoV-2, HIV-1 | - | [39,40] |
3-(aminocarbonyl)-1-phenylpyridinium; 2,3-dichloroaphthoquinone | Mpro (Cys144, Glu165, Gln191) | PEDV, FIPV | EC50 = 100 μM | [42] |
Hexachlorophenol | Mpro and ATPase | SARS-CoV | - | [43] |
Xanthohumol | Mpro | BVDV, HSV-1, HSV-2, RhV, PEDV, SARS-CoV-2 | IC50 = 1.53 µM and 7.51 µM | [44,45,46,47] |
Tomatidine | 3CLpro | PEDV, TGEV, PRRSV, EMCV, SVA, PEDV | - | [51] |